Malvern, PA, United States of America

Richard McCulloch Keenan

This inventor holds 25 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Compounds. Top assignees: Smithkline Beecham Corporation, Nps Pharmaceuticals, Inc., Optikira LLC. Active years: 1993-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard McCulloch Keenan. Retrieved from https://idiyas.com/inventor/richard-mcculloch-keenan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 84.0

 

Average Co-Inventor Count = 5.0

ph-index = 9

Forward Citations = 220(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1993)
  • US (1994)
  • Malvern, PA (US) (1993 - 2023)

Company Filing History:


Years Active: 1993-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Calcilytic Compounds
Fibrinogen Antagonists
IRE1 Inhibition
Platelet Aggregation
Vitronectin Receptor
Bicyclic Compounds
Urotensin-II Receptor
Angiotensin II Receptor
Imidazoles
Substituted Benzimidazoles
Pharmaceutical Methods
Receptor Antagonists
25 patents (USPTO):Explore Patents

Title: The Innovative Journey of Richard McCulloch Keenan

Introduction:

Richard McCulloch Keenan, a prolific inventor based in Malvern, PA, has made significant contributions to the field of medicine with his groundbreaking patented inventions. With a total of 25 patents to his name, Keenan's expertise and creativity have paved the way for advancements in treating various diseases and disorders.

Latest Patents:

Among his latest patents, Keenan introduced the world to "Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition." These compounds offer promising solutions for treating IRE1α-related diseases such as neurodegenerative diseases, cancer, and diabetes. Additionally, Keenan's work on "Calcilytic compounds" has opened new possibilities in inhibiting calcium receptor activity to achieve beneficial effects for patients.

Career Highlights:

Throughout his career, Keenan has made remarkable contributions while working at renowned companies such as SmithKline Beecham Corporation and NPS Pharmaceuticals, Inc. His relentless pursuit of innovation and problem-solving skills have set him apart as a visionary in the field of medical research and development.

Collaborations:

Keenan's success is also attributed to his collaborations with esteemed coworkers like James Francis Callahan and William Edward Bondinell. Together, they have synergized their talents and expertise to create novel solutions that have the potential to transform healthcare and improve patient outcomes.

Conclusion:

Richard McCulloch Keenan's exceptional talent, relentless dedication, and innovative mindset have positioned him as a leading figure in the world of patent inventions. His passion for pushing the boundaries of medical science and his commitment to addressing unmet medical needs continue to inspire future generations of inventors and researchers in shaping a healthier and brighter future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…